CYP19A1 and Alzheimer disease: The Epistasis Project by Medway et al. (2014) determined that 3 of the 4 single-nucleotide polymorphisms (SNPs) of CYP19 tested were associated with increased risk for AD in women but not in men (Medway et al., 2014).